PP160079 (Jibaja-Weiss, Montealegre)Aug 31, 2016 - Aug 30, 2020CPRIT
Leveraging a Community Network for Cancer Prevention to Increase HPC Vaccine Uptake and Completion among Pediatric Patients in a Safety Net Healthcare Setting
Role Description: This project uses a comprehensive approach to address barriers that exist at multiple stages within the continuum of vaccine delivery.
PP170094 (Jibaja-Weiss, Montealegre)Aug 30, 2017 - Aug 31, 2020CPRIT
Expanding a Community Network for Cancer Prevention to Improve Cervical and Colorectal Screening and Follow-up among an Urban Medically Underserved Population
Role Description: The goal of this program is to increase access to and completion of cervical and colorectal cancer screening among patients in a safety net health system.
(Rodriguez, Schmeler)Mar 1, 2019 - Feb 28, 2022CPRIT
School-Based Human Papillomavirus Vaccination Program in the Rio Grande Valley: Continuation and Expansion to Hidalgo County
Role Description: To expand and evaluate the performance of a school-based HPV vaccination program in the Rio Grande Valley of Texas.
R01MD013715 (MONTEALEGRE, JANE R)Apr 16, 2019 - Dec 31, 2023NIH
A Randomized Controlled Trial of Mail-Self Stamped HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System
Role: Principal Investigator
PP190051 (Montealegre, Jibaja-Weiss)Aug 30, 2019 - Aug 31, 2022CPRIT
Expanding a Community Network for Cancer Prevention to Increase HPV Vaccine Uptake and Tobacco Prevention in a Medically Underserved Pediatric Population
Role Description: The goals of this project are to increase the proportion of pediatric patients who complete the HPV vaccine series and to increase the proportion of pediatric patients who receive comprehensive tobacco prevention clinical services.
RP190641 (El-Serag)Aug 31, 2019 - Aug 31, 2024CPRIT
The Texas Collaborative Center for Hepatocellular Cancer Research
Role Description: The goal of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) is to reduce liver cancer mortality in Texas by reducing the number of people who develop cancer or detecting it early when it is curable.